News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Morgan Stanley warns prolonged high oil prices could cause a stagflationary shock, pressuring consumption and corporate margins.
  • Barings limited redemptions at a private credit fund to 5% after investors requested 11.3% withdrawals.
  • Bank of America flags systematic CTAs as a source of selling pressure across equities and bonds.
  • BlackRock filed for an iShares Nasdaq-100 ETF (IQQ), challenging Invesco's dominant QQQ.
  • Supreme Court cleared DOJ to seek dismissal of Steve Bannon's contempt conviction, returning the case to a lower court.
  • NRC will end agency-led 'force-on-force' reactor security drills after 2028, shifting to training-oriented independent oversight.
  • Fubo raised fiscal 2026–28 adjusted EBITDA targets and projected positive free cash flow by 2027, lifting shares about 3%.

Latest Articles

Dynatrace EVP Purchases $107,250 of Company Stock Amid Mixed Analyst Views

Dynatrace EVP Purchases $107,250 of Company Stock Amid Mixed Analyst Views

Dynatrace Executive Vice President and Chief Customer Officer Stephen A. McMahon acquired 3,000 shares of Dynatrace common stock on March 3, 2026, for $35.75 per share, a transaction valued at $107,250. The filing shows McMahon now directly holds 3,454 shares. The insider buy follows a 25% decline in the stock over the prior six months; shares have…

Morgan Stanley to Cut About 2,500 Jobs in Global Reduction

Morgan Stanley to Cut About 2,500 Jobs in Global Reduction

Morgan Stanley will eliminate approximately 2,500 roles, equivalent to about 3% of its workforce, with reductions taking place across the bank’s three principal divisions and in both domestic and international offices. The move coincides with a broader round of reductions at major U.S. companies, some of which have been linked to efficiency gains f…

Hayward Holdings CEO Executes $824,021 Stock Sale, Exercises Options

Hayward Holdings CEO Executes $824,021 Stock Sale, Exercises Options

Hayward Holdings President and CEO Kevin Holleran disposed of 52,389 shares on March 2, 2026, using a weighted average sale price of $15.7289 for proceeds of about $824,021. The Form 4 filing also shows option exercises and share acquisitions, along with share dispositions to satisfy tax obligations. The company recently reported fourth-quarter 202…

Corporate America Continues Major Job Reductions in Early 2026 as Firms Pursue Efficiency and AI Reallocation

Corporate America Continues Major Job Reductions in Early 2026 as Firms Pursue Efficiency and AI Reallocation

Through the opening months of 2026 a wide swath of U.S. companies announced layoffs and restructuring plans as they streamline operations and reallocate resources toward artificial intelligence and higher-priority initiatives. Announcements span technology platforms, manufacturing, retail and financial services, with individual reductions ranging f…

SiTime Director Sells 501 Shares as Stock Nears 52-Week High

SiTime Director Sells 501 Shares as Stock Nears 52-Week High

SiTime Corp director Raman Chitkara sold 501 shares of common stock on March 2, 2026, generating $212,940 in proceeds. The sales occurred while the stock traded near its 52-week high, and follow quarterly results that exceeded analyst expectations for both earnings and revenue. Market commentary from InvestingPro flags valuation concerns despite an…

Western Digital: Backing AI’s Storage Boom - A $310 Trade Thesis

Western Digital: Backing AI’s Storage Boom - A $310 Trade Thesis

Western Digital sits at the intersection of hyperscale storage demand and legacy HDD scale economics. With multi-year cloud contracts, improving margins and a market cap near $88.5B, WDC is a plausible play on continued AI data-center spending. This trade idea lays out an actionable long with a clear entry, stop and target, plus the catalysts and r…

Morgan Stanley to Reduce Global Workforce by About 3%

Morgan Stanley to Reduce Global Workforce by About 3%

Morgan Stanley is implementing a worldwide headcount reduction of roughly 3%, affecting employees across its investment banking, trading, wealth and asset management divisions. The move, which impacts both client-facing and operational roles, is tied to individual performance evaluations and shifts in business priorities and location strategy. With…

CarGurus Director Makes $1.0M Purchase; Shares Rise Amid Mixed Signals

CarGurus Director Makes $1.0M Purchase; Shares Rise Amid Mixed Signals

CarGurus Inc director Stephen Kaufer purchased 30,766 shares of Class A common stock on March 3, 2026, at a weighted average price of $32.5044, for a total of $1,000,033. The stock has since traded up to $33.53. The transaction increases Kaufer's direct holdings to 323,939.105 shares and comes alongside company revenue growth, a reduced analyst pri…

Markets Catch a Breath as Middle East Tensions Ease; PMIs Show Resilient Activity

Markets Catch a Breath as Middle East Tensions Ease; PMIs Show Resilient Activity

Global equity markets climbed on Wednesday as signs that hostilities in the Middle East might de-escalate, together with calmer energy markets, prompted investors to unwind some positions. Economic surveys for February showed broadly firm activity across the United States, China and Europe. Separately, President Trump formally submitted Kevin Warsh…

PepGen Shares Tumble After FDA Places Partial Hold on FREEDOM2-DM1 Trial

PepGen Shares Tumble After FDA Places Partial Hold on FREEDOM2-DM1 Trial

PepGen Inc. saw its stock fall 26% in after-hours trading after the U.S. Food and Drug Administration placed a partial clinical hold on the company’s FREEDOM2-DM1 Phase 2 trial. The hold centers on questions about previously submitted preclinical pharmacology and toxicology studies for PGN-EDODM1, the company’s candidate for myotonic dystrophy type…